NASDAQ: ALLO - Allogene Therapeutics

Yield per half year: -46.04%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Allogene Therapeutics

Extended chart Simple chart
Financial Markets by TradingView

About Allogene Therapeutics

Allogene Therapeutics, Inc., иммуноонкологическая компания клинической стадии, занимается исследованиями, разработкой и коммерциализацией генно-инженерных методов лечения аллогенными Т-клетками для лечения рака. Компания была основана в 2017 году, ее штаб-квартира находится в Южном Сан-Франциско, Калифорния.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2018-10-11
ISIN US0197701065
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://www.allogene.com
Цена ао 1.43
Change price per day: 0% (1.43)
Change price per week: -10.63% (1.6)
Change price per month: -25.52% (1.92)
Change price per 3 month: -41.87% (2.46)
Change price per half year: -46.04% (2.65)
Change price per year: -71.17% (4.96)
Change price per 3 year: -84.66% (9.32)
Change price per 5 year: -95.75% (33.65)
Change price per 10 year: 0% (1.43)
Change price per year to date: -34.7% (2.19)
All parameters

Underestimation

Title Value Grade
P/S 5087.89 1
P/BV 0.9436 9
P/E 0 0
EV/EBITDA -1.73 0
Total: 3.88

Efficiency

Title Value Grade
ROA, % -50.91 0
ROE, % -63.89 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.3314 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % -99.75 0
Yield Ebitda, % 62.41 8
Yield EPS, % 13.96 2
Total: 4.4
More

Transaction date Date of disclosure Insider Type Price Volume Quantity Share before, % Share after, % Document
09.12.2024 09.12.2024 MESSEMER DEBORAH M.
Director		 Purchase 2.18 19 916 9136 0 0.01 link
03.12.2024 02.12.2024 Humer Franz B
Director		 Purchase 2.48 22 868 9221 0 0.01 link
21.10.2024 21.10.2024 Parker Geoffrey M.
Officer		 Purchase 2.84 103 387 36404 0 0.03 link
21.08.2024 21.08.2024 Douglas Earl Martin
Officer		 Purchase 2.79 78 985 28310 0 0.02 link
30.05.2024 03.06.2024 Humer Franz B
Director		 Sale 2.34 26 208 11200 0 -0.01 link
16.05.2024 20.05.2024 Belldegrun Arie
Director		 Purchase 2.9 5 000 000 1724137 0 1.21 link
30.01.2024 06.03.2024 Parker Geoffrey M.
CHIEF FINANCIAL OFFICER		 Purchase 3.6 684 190 0 0 link
17.01.2023 18.01.2023 Bhavnagri Veer
General Counsel		 Sale 7.04 21 120 3000 0 0 link

Institutions Volume Share, %
FMR, LLC 25241499 14.93
TPG GP A, LLC 18716306 11.07
Blackrock Inc. 10001804 5.92
Vanguard Group Inc 9030825 5.34
JP Morgan Chase & Company 6906761 4.08
PRIMECAP Management Company 5281886 3.12
Citadel Advisors Llc 4053226 2.4
Goldman Sachs Group Inc 3337214 1.97
Woodline Partners LP 2577500 1.52
State Street Corporation 2427284 1.44

ETF Share, % Profitability for 1 year, % Dividends, %
Range Cancer Therapeutics ETF 0.87559 47.24 0.11955
Virtus LifeSci Biotech Clinical Trials ETF 0.873 63.04 0.33
WisdomTree BioRevolution Fund 0.62859 -4.69 0.78691
Global X Genomics & Biotechnology ETF 0.51819 2.58 0.15585
ProShares UltraShort Nasdaq Biotechnology 0.37 -40.36 1.76
Amplify Etho Climate Leadership U.S. ETF 0.21276 22.79 1.41942
SPDR S&P Kensho New Economies Composite ETF 0.11186 21.57 0.88486
Direxion Daily S&P Biotech Bull 3x Shares 0.10123 4067.92 0.25924
Invesco Nasdaq Biotechnology ETF 0.05856 28.58 0.8565
Goldman Sachs Innovate Equity ETF 0.0573 29.66 1.20987
Future Tech ETF 0.0567 426.34 0.8416
Principal Healthcare Innovators ETF 0.0567 618.5 0.8416
ProShares Ultra Nasdaq Biotechnology 0.03996 51.7 0.85651
Avantis U.S Small Cap Equity ETF 0.03918 27.77 1.68271
Schwab U.S. Small-Cap ETF 0.01136 17.47 1.51433
Vanguard Russell 2000 ETF 0.01 17.16 1.48801
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.00956 17.58 1.75869
Dimensional U.S. Targeted Value ETF 0.00741 26.01 1.93487
ProShares UltraPro Russell2000 0.00636 89.82 1.47873
Fidelity MSCI Health Care Index ETF 0.00607 3 1.46057
SPDR Portfolio MSCI Global Stock Market ETF 0.00463 17.99 2.19607
Dimensional U.S. Core Equity 2 ETF 0.00377 30.76 1.47098
ProShares Hedge Replication ETF 0.00185 5.92 1.47892
Dimensional US Core Equity Market ETF 0.00112 30.98 1.40618
Schwab U.S. Broad Market ETF 0.00109 24.86 1.43354
Avantis U.S. Equity ETF 0.00051 23.04 1.59151
iShares Russell 3000 ETF 0.00047 24.83 1.43482
Dimensional U.S. Equity ETF 0.00043 31.53 1.3557
Vanguard Russell 3000 ETF 0 31.87 1.43817



Head Job title Payment Year of birth
Dr. David D. Chang M.D., Ph.D. Co-Founder, President, CEO & Director 1.1M 1960 (65 years)
Mr. Joshua A. Kazam Co-Founder & Director 711k 1977 (48 years)
Ms. Christine Cassiano Executive VP, Chief Corporate Affairs & Brand Strategy Officer N/A
Ms. Susan R. Lundeen Chief People Officer N/A 1966 (59 years)
Mr. Timothy L. Moore Ph.D. Executive VP & Chief Technical Officer N/A 1961 (64 years)
Mr. Earl M. Douglas Esq. Senior VP, General Counsel, Compliance Officer & Corporate Secretary N/A 1963 (62 years)
Dr. Arie S. Belldegrun F.A.C.S., M.D. Co-Founder & Executive Chairman 714.25k 1949 (76 years)
Dr. Zachary J. Roberts M.D., Ph.D. Executive VP of Research & Development and Chief Medical Officer N/A 1978 (47 years)
Mr. Geoffrey M. Parker Executive VP & CFO 1965 (60 years)
Ms. Annie Yoshiyama Senior VP, Corporate Controller & Principal Accounting Officer 1984 (41 year)

Address: United States, South San Francisco, CA , 210 East Grand Avenue - open in Google maps, open in Yandex maps
Website: http://www.allogene.com